802592

Novo Nordisk Pharmaceutical Industries LP — FEI 1000158576

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clayton, NC (United States)